In 2006, the baby boom generation (those born from 1946 - 1964) started turning 60 at the rate of 330 per hour ...
In a giant leap forward in ICD patient safety, the American College of Cardiology Foundation (ACCF), in conjunction with the Heart Rhythm Society (HRS), established the National Cardiovascular Data Registry's national ICD Registry in the fall of 2005 to measure ICD patient outcomes and track patient trends.
Arrow’s Transradial introducers provide for durable radial artery access while being vessel friendly. Our newest kit contains our .018 micro-puncture wire guide and needle set to minimize vessel trauma. The 6 French sheath and dilator track well over the smaller wire and we’ve applied a hydrophilic coating on the polyurethane sheath to enhance insertion and removal.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Sometimes it's the smallest things that leave the strongest impression. Of the dozens of technologies with which I came ...
When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose pumping power is weaker than normal, physicians are facing a paradox.
If the cardiologists at the University of Mississippi Medical Center (UMC) in Jackson have been facing an uphill battle ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Examples of physicians’ declining use of drug-eluting stents are growing. According to Dr. Louis Cannon, Cardiac & ...
In the simplest of terms, a ventricular assist device (VAD) is a battery-operated mechanical pump that helps a weakened ...
Technological trendsetters within the cardiology arena have been embarking on a path of seamless integration of their ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 8, 2007 - OBS Medical and Physio-Control Inc., a wholly-owned subsidiary of Medtronic Inc., announced they have ...
In the world of cardiologists who treat adults with congenital heart disease, the unusual is not so very unusual and the rare is fairly commonplace. Take Wendy Book, M.D., for example — this week she might meet for the first time a patient presenting with a heart defect from birth for which there is no standard therapy, and for whom there may well be no exact replica on record.
May 7, 2007 — Thoratec Corp., a global maker of products to treat cardiovascular disease, says the FDA has approved an ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 7, 2007 — Steven E. Nissen, M.D., chairman of the Department of Cardiovascular Medicine at Cleveland Clinic, and immediate past president of the American College of Cardiology, has been named one of the 100 Most Influential People by Time magazine. He will be featured among other "Scientists and Thinkers."
May 7, 2007 — Australia's adult stem cell company, Mesoblast Limited, has announced that the FDA has cleared the Investigational New Drug Submission (IND) of its U.S.-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf,’ adult stem cells for patients with heart attacks.
May 7, 2007 — Citing issues related to potentially suboptimal therapeutic dosing of paclitaxel, Conor Medsystems, LLC ...